Since the NCI Site Visit to the UNM Cancer Center in May 2005 and receipt of the detailed CCSG review. The University of New Mexico Cancer Center has undertaken very extensive internal planning and evaluation. The Cancer Center initiated a strategic planning process to improve evaluation of the Cancer Center. We have held four full meetings of our UNM Cancer Center External Scientific Advisory Board (ESAB) in: November 2006, June 2007, and May 2008 and May, 2009. In addition, we have coordinated several visits to our institution from individual members of our ESAB or other invited experts to review each program or special activity. We have focused our analyses on our overall strategic plans and on the strengths, weaknesses, opportunities, focus, and design of each of our Research Programs, their Associated Clinical Working Groups, and our Shared Resources. We have carefully considered the detailed critiques provided by the NCI Review Panel for our P30 CCSG and our ESAB and individual consultants. We have had weekly meetings of the UNM Cancer Center Senior Leadership group for the past year and regular meetings of the Cancer Center Research Program, Clinical Working Group, and Shared Resource Directors. We have also activated an institution-wide Cancer Center Seminar Series held the 3rd and 4th Tuesday of each month, where selected Program Members present highlights of their science. This very popular luncheon seminar regulariy attracts over 50 Cancer Center-associated faculty as well as other faculty and staff from the Health Sciences Center; the series has further enhanced awareness and interactions among excellent program scientists. We have described our ongoing planning and evaluation activities in some detail in the Director's Scientific Overview (Section 6) and each of the Research Program Reports (Section 8). As previously described, over the past 4 years, we have made changes in our Senior Leadership, have appointed new Program Leaders, and have adjusted the focus and scope of our Research Programs, particulariy in Cancer Biology & Biotechnology. In part due to anticipation of our competitive renewal, we have also completed a new 5 year detailed Strategic Plan for the next phase of development of our Center overall, with specific plans for each of our Programs and Resources.

Public Health Relevance

UNM Cancer Center planning and evaluation processes are to responsive external review which facilitate the identification of areas of strength, weakness and opportunities and their incorporation into strategic planning.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA118100-08S1
Application #
8545048
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$7,778
Indirect Cost
$2,627
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Pallikkuth, Sandeep; Martin, Cheyenne; Farzam, Farzin et al. (2018) Sequential super-resolution imaging using DNA strand displacement. PLoS One 13:e0203291
Leng, Shuguang; Picchi, Maria A; Kang, Huining et al. (2018) Dietary Nutrient Intake, Ethnicity, and Epigenetic Silencing of Lung Cancer Genes Detected in Sputum in New Mexican Smokers. Cancer Prev Res (Phila) 11:93-102
Peretti, Amanda S; Dominguez, Dayna; Grimes, Martha M et al. (2018) The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice. Am J Pathol 188:515-524
Brandsma, Arianne M; Schwartz, Samantha L; Wester, Michael J et al. (2018) Mechanisms of inside-out signaling of the high-affinity IgG receptor Fc?RI. Sci Signal 11:
Zheng, Handong; Wu, Dandan; Wu, Xiang et al. (2018) Leptin Promotes Allergic Airway Inflammation through Targeting the Unfolded Protein Response Pathway. Sci Rep 8:8905
Ray, Anita L; Berggren, Kiersten L; Restrepo Cruz, Sebastian et al. (2018) Inhibition of MK2 suppresses IL-1?, IL-6, and TNF-?-dependent colorectal cancer growth. Int J Cancer 142:1702-1711
Hudson, Laurie G; Gillette, Jennifer M; Kang, Huining et al. (2018) Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase. Cancers (Basel) 10:
Licon-Munoz, Yamhilette; Fordyce, Colleen A; Hayek, Summer Raines et al. (2018) V-ATPase-dependent repression of androgen receptor in prostate cancer cells. Oncotarget 9:28921-28934
Palsuledesai, Charuta C; Surviladze, Zurab; Waller, Anna et al. (2018) Activation of Rho Family GTPases by Small Molecules. ACS Chem Biol 13:1514-1524
Sallmyr, Annahita; Tomkinson, Alan E (2018) Repair of DNA double-strand breaks by mammalian alternative end-joining pathways. J Biol Chem 293:10536-10546

Showing the most recent 10 out of 344 publications